Disruption of the HPA-axis through corticosterone-release pellets induces robust depressive-like behavior and reduced BDNF levels in mice

Neuroscience Letters

Volumn 626, Issue , 2016, Pages 119-125

  Demuyser, Thomas ^a   Bentea, Eduard ^a   Deneyer, Lauren ^a   Albertini, Giulia ^a   Massie, Ann ^a   Smolders, Ilse ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

BDNF; Corticosterone; Depression; GR; Neurotransmitters; Pellet

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOSTERONE; DEXTRO SERINE; DOPAMINE; GLUCOCORTICOID RECEPTOR; GLUTAMIC ACID; MONOAMINE; NORADRENALIN; SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOSTERONE RELEASE; FACE VALIDITY; HIPPOCAMPUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR DEPRESSION; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; ANIMAL BEHAVIOR; BLOOD; C57BL MOUSE; CHEMICALLY INDUCED; DEPRESSION; DRUG EFFECTS; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS; METABOLISM; PHENOTYPE;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN-DERIVED NEUROTROPHIC FACTOR; CORTICOSTERONE; DEPRESSION; DOPAMINE; GLUTAMIC ACID; HIPPOCAMPUS; HYPOTHALAMUS; MALE; MICE; MICE, INBRED C57BL; NOREPINEPHRINE; NUCLEUS ACCUMBENS; PHENOTYPE; PITUITARY-ADRENAL SYSTEM; RECEPTORS, GLUCOCORTICOID; SEROTONIN;

EID: 84971317343     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2016.05.026     Document Type: Article

References (25)

1. Ardayfio P., Kim K.S. Anxiogenic-like effect of chronic corticosterone in the light-dark emergence task in mice. Behav. Neurosci. 2006, 120:249-256.
2. Bai F., Li X., Clay M., Lindstrom T., Skolnick P. Intra- and interstrain differences in models of behavioral despair. Pharmacol. Biochem. Behav. 2001, 70:187-192.
3. Bodnoff S.R., Humphreys A.G., Lehman J.C., Diamond D.M., Rose G.M., Meaney M.J. Enduring effects of chronic corticosterone treatment on spatial learning, synaptic plasticity, and hippocampal neuropathology in young and mid-aged rats. J. Neurosci. 1995, 15:61-69.
4. Castagné V., Moser P., Roux S., Porsolt R.D. Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice. Curr. Protoc. Neurosci. 2011, Apr Chapter 8:Unit 8.10A. 10.1002/0471142301.ns0810as55.
5. Coburn-Litvak P.S., Tata D.A., Gorby H.E., McCloskey D.P., Richardson G., Anderson B.J. Chronic corticosterone affects brain weight, and mitochondrial but not glial volume fraction in hippocampal area CA3. Neuroscience 2004, 124:429-438.
6. Cryan J.F., Mombereau C., Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci. Biobehav. Rev. 2005, 29:571-625.
7. David D.J., Samuels B.A., Rainer Q., Wang J.W., Marsteller D., Mendez I., Drew M., Craig D.A., Guiard B.P., Guilloux J.P., Artymyshyn R.P., Gardier A.M., Gerald C., Antonijevic I.A., Leonardo E.D., Hen R. Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 2009, 62:479-493.
8. Demuyser T., Deneyer L., Bentea E., Albertini G., Van Liefferinge J., Merckx E., De Prins A., De Bundel D., Massie A., Smolders I. In-depth behavioral characterization of the corticosterone mouse model and the critical involvement of housing conditions. Physiol. Behav. 2015, 156:199-207.
9. El Arfani A., Albertini G., Bentea E., Demuyser T., Van Eeckhaut A., Smolders I., Massie A. Alterations in the motor cortical and striatal glutamatergic system and d-serine levels in the bilateral 6-hydroxydopamine rat model for Parkinson's disease. Neurochem. Int. 2015, 88:88-96.
10. Fonio E., Benjamini Y., Golani I. Short and long term measures of anxiety exhibit opposite results. PLoS One 2012, 7:e48414.
11. Gourley S.L., Kiraly D.D., Howell J.L., Olausson P., Taylor J.R. Acute hippocampal brain-derived neurotrophic factor restores motivational and forced swim performance after corticosterone. Biol. Psychiatry 2008, 64:884-890.
12. Hodes G.E., Brookshire B.R., Hill-Smith T.E., Teegarden S.L., Berton O., Lucki I. Strain differences in the effects of chronic corticosterone exposure in the hippocampus. Neuroscience 2012, 222:269-280.
13. Khalid A., Kim B.S., Chung M.K., Ye J.C., Jeon D. Tracing the evolution of multi-scale functional networks in a mouse model of depression using persistent brain network homology. NeuroImage 2014, 101:351-363.
14. Kilkenny C., Browne W., Cuthill I.C., Emerson M., Altman D.G. Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br. J. Pharmacol. 2010, 160:1577-1579.
15. Koike H., Iijima M., Chaki S. Effects of ketamine and LY341495 on the depressive-like behavior of repeated corticosterone-injected rats. Pharmacol. Biochem. Behav. 2013, 107:20-23.
16. Mei L., Mochizuki M., Hasegawa N. Pycnogenol ameliorates depression-like behavior in repeated corticosterone-induced depression mice model. BioMed Res. Int. 2014, 2014:942927.
17. Mora F., Segovia G., Del Arco A., de Blas M., Garrido P. Stress neurotransmitters, corticosterone and body-brain integration. Brain Res. 2012, 1476:71-85.
18. Murray F., Smith D.W., Hutson P.H. Chronic low dose corticosterone exposure decreased hippocampal cell proliferation, volume and induced anxiety and depression like behaviours in mice. Eur. J. Pharmacol. 2008, 583:115-127.
19. Porsolt R.D., Bertin A., Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 1977, 229:327-336.
20. Rainer Q., Xia L., Guilloux J.P., Gabriel C., Mocaer E., Hen R., Enhamre E., Gardier A.M., David D.J. Beneficial behavioural and neurogenic effects of agomelatine in a model of depression/anxiety. Int. J. Neuropsychopharmacol. 2012, 15:321-335.
21. Samuels B.A., Leonardo E.D., Dranovsky A., Williams A., Wong E., Nesbitt A.M., McCurdy R.D., Hen R., Alter M. Global state measures of the dentate gyrus gene expression system predict antidepressant-sensitive behaviors. PLoS One 2014, 9:e85136.
22. Samuels B.A., Leonardo E.D., Gadient R., Williams A., Zhou J., David D.J., Gardier A.M., Wong E.H., Hen R. Modeling treatment-resistant depression. Neuropharmacology 2011, 61:408-413.
23. Sturm M., Becker A., Schroeder A., Bilkei-Gorzo A., Zimmer A. Effect of chronic corticosterone application on depression-like behavior in C57BL/6 N and C57BL/6J mice. Genes Brain Behav. 2015, 14:292-300.
24. Sturm M., Becker A., Schroeder A., Bilkei-Gorzo A., Zimmer A. Impact of chronic corticosterone application on depression-like behavior in C57BL/6 N and C57BL/6J mice. Genes Brain Behav. 2015, 14(March (3)):292-300.
25. van Donkelaar E.L., Vaessen K.R., Pawluski J.L., Sierksma A.S., Blokland A., Canete R., Steinbusch H.W. Long-term corticosterone exposure decreases insulin sensitivity and induces depressive-like behaviour in the C57BL/6NCrl mouse. PLoS One 2014, 9:e106960.